ArticleMolecules (Basel, Switzerland)2021

In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates.

Angel J Ruiz-Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.